Twist Bioscience Corporation (BIT:1TWST)

Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	210.44	226.32	286.47	378.69	465.83	93.67
Short-Term Investments	46.71	50.08	49.94	126.28	12.03	196.34
Cash & Short-Term Investments	257.15	276.4	336.41	504.97	477.86	290
Cash Growth	-12.34%	-17.84%	-33.38%	5.67%	64.78%	109.98%
Accounts Receivable	49.95	34.9	44.06	40.29	26.21	25.43
Other Receivables	1.2	-	-	-	2.34	0.95
Receivables	51.15	34.9	44.06	40.29	28.55	26.38
Inventory	20.86	24.08	32.06	39.31	31.8	12.29
Prepaid Expenses	9.29	11.4	11.72	11.91	8.28	6.2
Total Current Assets	338.44	346.78	424.26	596.48	546.5	334.87
Property, Plant & Equipment	151.21	161.35	203.36	214.39	105.7	59.17
Goodwill	85.81	85.81	85.81	85.81	22.43	1.14
Other Intangible Assets	13.95	14.48	54.48	59.74	18.26	0.31
Other Long-Term Assets	6.2	5.91	8.49	4.96	6.18	3.4
Total Assets	595.62	614.32	776.4	961.38	702.1	398.88
Accounts Payable	8.06	1.63	14.05	20.09	14.9	4.83
Accrued Expenses	44.49	48.75	36.57	37.19	28.76	18.85
Current Portion of Long-Term Debt	-	-	-	-	1.55	3.33
Current Portion of Leases	15.22	14.81	14.9	13.64	8.21	6.41
Current Income Taxes Payable	4.09	2.73	4.37	3.66	2.44	0.72
Current Unearned Revenue	2.66	2.13	3	3.48	1.09	-
Other Current Liabilities	0.46	0.96	0.43	12.6	6.1	1.89
Total Current Liabilities	74.98	71.01	73.32	90.66	63.05	36.03
Long-Term Debt	-	-	-	-	-	1.4
Long-Term Leases	65.08	70.22	79.17	81.27	53.16	24.84
Other Long-Term Liabilities	0.45	0.41	0.48	0.06	5.07	0.35
Total Liabilities	155.51	141.63	152.97	171.99	121.28	62.62
Additional Paid-In Capital	1,754	1,715	1,657	1,620	1,191	794.63
Retained Earnings	-1,313	-1,242	-1,033	-828.42	-610.55	-458.46
Comprehensive Income & Other	-0.66	-0.52	-0.76	-1.84	0.55	0.09
Total Common Equity	440.11	472.69	623.43	789.39	580.82	336.26
Shareholders' Equity	440.11	472.69	623.43	789.39	580.82	336.26
Total Liabilities & Equity	595.62	614.32	776.4	961.38	702.1	398.88
Total Debt	80.3	85.03	94.07	94.91	62.92	35.98
Net Cash (Debt)	176.85	191.37	242.34	410.06	414.94	254.02
Net Cash Growth	-13.27%	-21.03%	-40.90%	-1.18%	63.35%	94.84%
Net Cash Per Share	3.00	3.30	4.26	7.61	8.60	6.48
Filing Date Shares Outstanding	59.92	59.36	57.67	56.57	49.63	45.15
Total Common Shares Outstanding	59.86	58.88	57.56	56.52	49.5	45.08
Working Capital	263.47	275.77	350.93	505.82	483.44	298.84
Book Value Per Share	7.35	8.03	10.83	13.97	11.73	7.46
Tangible Book Value	340.35	372.4	483.14	643.84	540.13	334.82
Tangible Book Value Per Share	5.69	6.33	8.39	11.39	10.91	7.43
Machinery	107.61	105.93	111.18	67.43	53.61	41.9
Construction In Progress	9.3	4.69	8.53	87.72	16.97	4.7
Leasehold Improvements	57.46	57.45	57.27	14.37	5.07	4.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.